BPDA Delays Fort Point Lab Conversion
Boston Planning & Development Agency directors approved over 480,000 square feet of real estate projects Thursday, while putting the brakes on a proposed lab conversion in Fort Point.
Boston Planning & Development Agency directors approved over 480,000 square feet of real estate projects Thursday, while putting the brakes on a proposed lab conversion in Fort Point.
As it pivots from office to suburban life science projects, Boston Properties is proposing a redevelopment of a Lexington office park to create 425,450 square feet of office and lab space.
The new owners of a Westwood office building are set to begin a lab conversion that would become available to life science tenants in 2023.
A high-visibility Downtown Crossing office building could become one of Boston’s next lab conversions following a $107-million acquisition.
An office building across from Boston’s South Station will become life science research space after a developer confirmed no high-risk infectious disease research will be conducted.
A New York investor has joined the ownership of two Davis Cos. properties, including a Wellington Circle lab conversion that recently secured its first life science tenant.
A firm that’s converting three Boston office buildings into life science space has completed its largest acquisition to date in a $238 million deal for the Independence Wharf property.
A pair of 1990s-era office buildings are set for conversion into a nearly 234,000-square-foot life science complex in Andover.
A Fort Point office building has been sold to a San Francisco investor for $74.6 million with plans for a lab conversion.
The Revolution Labs speculative life science conversion in Lexington has received its first lease commitment from a publicly-traded biotech company.
A life science developer that specializes in speculative lab suite conversions has made its third and largest acquisition in Boston with the $210 million purchase of 2 Financial Center.
Boston Planning & Development Agency officials approved two new life science projects in the Seaport District, including one that’s already landed an anchor tenant, and construction of 255 housing units.
The departure of anchor tenant WeWork is providing the impetus for the latest proposed office-to-lab conversion in downtown Boston.
A life science developer that’s partnering on Harvard University’s next Allston project is adding an East Cambridge office property to its real estate portfolio.
Boston Planning & Development Agency officials approved proposals to build 544 housing units and conversion of a pair of commercial buildings in South Boston and the South End into laboratory space.
Life science developer Alexandria Real Estate Equities is finding new opportunities for growth in the Cambridge industry epicenter with an agreement to buy the One Charles Park and One Rogers Street office buildings for $815 million and convert them to lab space.
A Fort Point office building that served as General Electric’s headquarters when it moved to Boston is being marketed for a potential life science conversion.
Boston Properties added to its suburban life science portfolio with the $100 million acquisition of a pair of Waltham lab properties totaling 153,000 square feet.
A 7.8-million-square-foot pipeline of office building conversions to lab-ready space accounts for nearly 30 percent of Greater Boston’s life science inventory, exceeding the national average for commercial real estate markets.
Greatland Realty Partners is the first developer to respond to the town of Lexington’s Hartwell Innovation Park (HIP) rezoning with its acquisition of a four-building, 289,000-square-foot complex.